Cinda Securities maintains Zhenghai Biological's buy rating for the first quarter of the review report: Overcoming the impact of the epidemic and the rapid growth of new products will be launched soon_Oriental Fortune Network

Key Data Concepts:   

? These are the company names, stock quotes, topics, and entities related to this data.

300653 300713 Fortune Ng Fung Food Shenzhenrease Technology Yantai Zhenghai Bio-Tech Research, Development Paper, Packaging Product Interest Rate Market, Exchange Securities Epidemic

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets

Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!

Already have an account?
Login

Home » News » Cinda Securities maintains Zhenghai Biological's buy rating for the first quarter of the review report: Overcoming the impact of the epidemic and the rapid growth of new products will be launched soon_Oriental Fortune Network